STOCK TITAN

[144] Hexcel Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Hexcel Corporation (HXL) filed a Form 144 indicating a proposed sale of 911 shares of common stock through Fidelity Brokerage Services LLC with an aggregate market value of $59,215.00. The filing lists the companys outstanding shares as 79,563,346 and an approximate sale date of 09/02/2025 on the NYSE. The 911 shares were acquired through restricted stock vesting on 01/29/2025 (133 shares), 01/30/2025 (112 shares), and 01/31/2025 (666 shares) and were paid as compensation. The filer reports no securities sold in the past three months for the account to be sold. The notice includes the required representation that the seller is not aware of undisclosed material adverse information and references possible reliance on a Rule 10b5-1 plan if applicable.

Hexcel Corporation (HXL) ha depositato un Form 144 indicando la proposta di vendita di 911 azioni ordinarie tramite Fidelity Brokerage Services LLC per un valore complessivo di $59.215,00. Il deposito riporta azioni in circolazione pari a 79.563.346 e una data approssimativa di vendita il 02/09/2025 sulla NYSE. Le 911 azioni sono state acquisite tramite vestizione di azioni vincolate il 29/01/2025 (133 azioni), il 30/01/2025 (112 azioni) e il 31/01/2025 (666 azioni) e sono state corrisposte come compenso. Il dichiarante segnala che non sono stati venduti titoli negli ultimi tre mesi per il conto da alienare. L’avviso include la dichiarazione richiesta che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate e fa riferimento a un possibile ricorso a un piano ai sensi della Regola 10b5-1, se applicabile.

Hexcel Corporation (HXL) presentó un Formulario 144 indicando una propuesta de venta de 911 acciones ordinarias a través de Fidelity Brokerage Services LLC por un valor total de $59,215.00. La presentación enumera las acciones en circulación de la compañía como 79,563,346 y una fecha aproximada de venta el 02/09/2025 en la NYSE. Las 911 acciones se adquirieron mediante conversión/vestido de acciones restringidas el 29/01/2025 (133 acciones), el 30/01/2025 (112 acciones) y el 31/01/2025 (666 acciones) y se pagaron como compensación. El declarante informa que no se vendieron valores en los últimos tres meses para la cuenta a vender. El aviso incluye la representación requerida de que el vendedor no tiene conocimiento de información adversa material no divulgada y menciona la posible dependencia de un plan conforme a la Regla 10b5-1, si procede.

Hexcel Corporation(HXL)는 Form 144를 제출하여 Fidelity Brokerage Services LLC를 통해 보통주 911주를 총액 $59,215.00에 매도할 예정임을 밝혔습니다. 제출서에는 회사의 발행주식 수를 79,563,346주로 기재하고 있고, NYSE에서의 예상 매도일을 2025-09-02로 표기했습니다. 해당 911주는 제한주(Restricted Stock) 베스팅으로 2025-01-29(133주), 2025-01-30(112주), 2025-01-31(666주)에 취득되었으며 보상으로 지급되었습니다. 신고인은 해당 계정에 대해 과거 3개월간 매도한 증권이 없다고 보고했습니다. 공시는 판매자가 공개되지 않은 중요 불리정보를 알고 있지 않다는 필수 진술을 포함하며, 해당되는 경우 규칙 10b5-1 계획에 의존할 수 있음을 언급합니다.

Hexcel Corporation (HXL) a déposé un formulaire 144 indiquant la vente proposée de 911 actions ordinaires via Fidelity Brokerage Services LLC pour une valeur totale de 59 215,00 $. Le dépôt indique le nombre d’actions en circulation à 79 563 346 et une date approximative de vente le 02/09/2025 à la NYSE. Les 911 actions ont été acquises par vesting d’actions restreintes le 29/01/2025 (133 actions), le 30/01/2025 (112 actions) et le 31/01/2025 (666 actions) et ont été versées en tant que rémunération. Le déclarant indique qu’aucun titre n’a été vendu au cours des trois derniers mois pour le compte à céder. L’avis comprend la représentation requise selon laquelle le vendeur n’a connaissance d’aucune information défavorable importante non divulguée et mentionne la possibilité de se fonder sur un plan en vertu de la règle 10b5-1, le cas échéant.

Hexcel Corporation (HXL) reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 911 Aktien des Stammkapitals über Fidelity Brokerage Services LLC mit einem Gesamtmarktwert von $59.215,00 angezeigt wird. Die Einreichung nennt die ausstehenden Aktien des Unternehmens mit 79.563.346 und ein ungefähr geplantes Verkaufsdatum am 02.09.2025 an der NYSE. Die 911 Aktien wurden durch Vesting eingeschränkter Aktien am 29.01.2025 (133 Aktien), 30.01.2025 (112 Aktien) und 31.01.2025 (666 Aktien) erworben und als Vergütung ausgegeben. Der Einreicher gibt an, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, die zu dem zu veräußernden Konto gehören. Die Mitteilung enthält die erforderliche Erklärung, dass der Verkäufer nicht von nicht offengelegten, wesentlichen nachteiligen Informationen Kenntnis hat, und verweist gegebenenfalls auf eine mögliche Nutzung eines Rule-10b5-1-Plans.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small, routine insider sale notice for 911 shares; immaterial relative to total float and does not signal material company change.

The Form 144 documents a proposed sale of 911 shares acquired via restricted stock vesting in late January 2025 and designated as compensation. The aggregate value of $59,215 versus an outstanding share base of 79,563,346 implies the transaction is de minimis from a market-impact perspective. The filing includes the standard attestation about non-public material information and notes no sales in the prior three months, which supports this being a routine, compliance-driven disclosure rather than an indication of company-specific, material developments.

TL;DR: Compliance-focused disclosure of vested compensation being sold; procedural and not materially adverse.

The submission shows securities obtained through restricted stock vesting and scheduled for sale through a broker on the NYSE. From a governance standpoint, the filing meets Rule 144 notification requirements and the seller affirms lack of undisclosed material information. The absence of prior three-month sales and the small size relative to outstanding shares indicate routine insider liquidity rather than a governance red flag. If a 10b5-1 plan exists, the filer is asked to note adoption date, but none is explicitly provided in the content.

Hexcel Corporation (HXL) ha depositato un Form 144 indicando la proposta di vendita di 911 azioni ordinarie tramite Fidelity Brokerage Services LLC per un valore complessivo di $59.215,00. Il deposito riporta azioni in circolazione pari a 79.563.346 e una data approssimativa di vendita il 02/09/2025 sulla NYSE. Le 911 azioni sono state acquisite tramite vestizione di azioni vincolate il 29/01/2025 (133 azioni), il 30/01/2025 (112 azioni) e il 31/01/2025 (666 azioni) e sono state corrisposte come compenso. Il dichiarante segnala che non sono stati venduti titoli negli ultimi tre mesi per il conto da alienare. L’avviso include la dichiarazione richiesta che il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate e fa riferimento a un possibile ricorso a un piano ai sensi della Regola 10b5-1, se applicabile.

Hexcel Corporation (HXL) presentó un Formulario 144 indicando una propuesta de venta de 911 acciones ordinarias a través de Fidelity Brokerage Services LLC por un valor total de $59,215.00. La presentación enumera las acciones en circulación de la compañía como 79,563,346 y una fecha aproximada de venta el 02/09/2025 en la NYSE. Las 911 acciones se adquirieron mediante conversión/vestido de acciones restringidas el 29/01/2025 (133 acciones), el 30/01/2025 (112 acciones) y el 31/01/2025 (666 acciones) y se pagaron como compensación. El declarante informa que no se vendieron valores en los últimos tres meses para la cuenta a vender. El aviso incluye la representación requerida de que el vendedor no tiene conocimiento de información adversa material no divulgada y menciona la posible dependencia de un plan conforme a la Regla 10b5-1, si procede.

Hexcel Corporation(HXL)는 Form 144를 제출하여 Fidelity Brokerage Services LLC를 통해 보통주 911주를 총액 $59,215.00에 매도할 예정임을 밝혔습니다. 제출서에는 회사의 발행주식 수를 79,563,346주로 기재하고 있고, NYSE에서의 예상 매도일을 2025-09-02로 표기했습니다. 해당 911주는 제한주(Restricted Stock) 베스팅으로 2025-01-29(133주), 2025-01-30(112주), 2025-01-31(666주)에 취득되었으며 보상으로 지급되었습니다. 신고인은 해당 계정에 대해 과거 3개월간 매도한 증권이 없다고 보고했습니다. 공시는 판매자가 공개되지 않은 중요 불리정보를 알고 있지 않다는 필수 진술을 포함하며, 해당되는 경우 규칙 10b5-1 계획에 의존할 수 있음을 언급합니다.

Hexcel Corporation (HXL) a déposé un formulaire 144 indiquant la vente proposée de 911 actions ordinaires via Fidelity Brokerage Services LLC pour une valeur totale de 59 215,00 $. Le dépôt indique le nombre d’actions en circulation à 79 563 346 et une date approximative de vente le 02/09/2025 à la NYSE. Les 911 actions ont été acquises par vesting d’actions restreintes le 29/01/2025 (133 actions), le 30/01/2025 (112 actions) et le 31/01/2025 (666 actions) et ont été versées en tant que rémunération. Le déclarant indique qu’aucun titre n’a été vendu au cours des trois derniers mois pour le compte à céder. L’avis comprend la représentation requise selon laquelle le vendeur n’a connaissance d’aucune information défavorable importante non divulguée et mentionne la possibilité de se fonder sur un plan en vertu de la règle 10b5-1, le cas échéant.

Hexcel Corporation (HXL) reichte ein Formular 144 ein, in dem ein geplanter Verkauf von 911 Aktien des Stammkapitals über Fidelity Brokerage Services LLC mit einem Gesamtmarktwert von $59.215,00 angezeigt wird. Die Einreichung nennt die ausstehenden Aktien des Unternehmens mit 79.563.346 und ein ungefähr geplantes Verkaufsdatum am 02.09.2025 an der NYSE. Die 911 Aktien wurden durch Vesting eingeschränkter Aktien am 29.01.2025 (133 Aktien), 30.01.2025 (112 Aktien) und 31.01.2025 (666 Aktien) erworben und als Vergütung ausgegeben. Der Einreicher gibt an, dass in den vergangenen drei Monaten keine Wertpapiere verkauft wurden, die zu dem zu veräußernden Konto gehören. Die Mitteilung enthält die erforderliche Erklärung, dass der Verkäufer nicht von nicht offengelegten, wesentlichen nachteiligen Informationen Kenntnis hat, und verweist gegebenenfalls auf eine mögliche Nutzung eines Rule-10b5-1-Plans.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Hexcel's (HXL) Form 144 report?

The filing reports a proposed sale of 911 common shares through Fidelity with an aggregate market value of $59,215.00 and an approximate sale date of 09/02/2025.

How were the 911 shares acquired according to the filing?

The shares were acquired via restricted stock vesting on 01/29/2025 (133 shares), 01/30/2025 (112 shares), and 01/31/2025 (666 shares) and were paid as compensation.

Is this a large sale relative to Hexcel's outstanding shares?

No. The filing lists 79,563,346 shares outstanding, so 911 shares are immaterial relative to the total share count.

Were any shares sold in the past three months by this account?

The filing states "Nothing to Report" for securities sold during the past three months.

Through which broker will the sale be executed?

The sale is to be executed through Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI.
Hexcel Corp

NYSE:HXL

HXL Rankings

HXL Latest News

HXL Latest SEC Filings

HXL Stock Data

5.02B
78.90M
0.84%
107.28%
6.07%
Aerospace & Defense
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
STAMFORD